See the rest here:
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
See the rest here:
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
Here is the original post:
Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China
Continue reading here:
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
See the original post here:
Havn Life Sciences announces increase in Bought Deal Financing to $10 Million
Go here to see the original:
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Read more from the original source:
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum